About Tinos Therapeutics
Tinos Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2023 in Delaware. It has reported $2,250,000 raised in one offering on Form D since September 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2025 | Sep 26, 2025amended Apr 17, 2026 | $2,250,000of $4.0M target | 3 | $750K | OptionsRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Tinos Therapeutics's Form D filed Apr 17, 2026.
DK
David Karambizi
Executive officer and director
AP
Anastasios Polimenakos
Director
NT
Nikolaos Tapinos
President and director